Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Baxter
Cipla
US Department of Justice
Teva
Merck
Boehringer Ingelheim
UBS
McKinsey

Generated: November 15, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Gevokizumab

« Back to Dashboard

US Patents for Gevokizumab

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Gevokizumab ➤ Try a Free Trial Methods of treating hemophagocytic lymphohistiocytosis with an IL-33 receptor antibody The Children's Hospital of Philadelphia (Philadelphia, PA) The Trustees of the University of Pennsylvania (Philadelphia, PA) ➤ Try a Free Trial
Gevokizumab ➤ Try a Free Trial Age-associated clonal hematopoiesis accelerates cardio-metabolic disease development TRUSTEES OF BOSTON UNIVERSITY (Boston, MA) ➤ Try a Free Trial
Gevokizumab ➤ Try a Free Trial Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein CureVac AG (Tubingen, DE) ➤ Try a Free Trial
Gevokizumab ➤ Try a Free Trial Method for the treatment of acne by administering IL-1.beta. antibody UNIVERSITAT ZURICH (Zurich, CH) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Gevokizumab

Drugname Country Document Number Estimated Expiration Related US Patent
Gevokizumab Canada 2946511 2034-04-21 ➤ Try a Free Trial
Gevokizumab European Patent Office 3134120 2034-04-21 ➤ Try a Free Trial
Gevokizumab World Intellectual Property Organization (WIPO) 2015164354 2034-04-21 ➤ Try a Free Trial
Gevokizumab World Intellectual Property Organization (WIPO) 2018022982 2036-07-29 ➤ Try a Free Trial
Gevokizumab Australia 2013220749 2032-02-15 ➤ Try a Free Trial
Gevokizumab Brazil 112014019627 2032-02-15 ➤ Try a Free Trial
Gevokizumab Canada 2862476 2032-02-15 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Argus Health
Merck
Cipla
Chinese Patent Office
Teva
Baxter
Moodys
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.